DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Omecamtiv mecarbil
Omecamtiv mecarbil
Old and New Intravenous Inotropic Agents in the Treatment Of
Mechanistic and Structural Basis for Activation of Cardiac Myosin Force
The Myosin Activator Omecamtiv Mecarbil: a Promising New Inotropic Agent
Qt9bv9g77p.Pdf
Study Protocol
Study Protocol
Dr. Almássy-CMC.Pdf
Javed Butler, MD, MPH
The Energy-Saving Effect of a New Myosin Activator, Omecamtiv Mecarbil, on LV Mechanoenergetics in Rat Hearts with Blood-Perfused Isovolumic Contraction Model
Novel Therapies in Heart Failure Liu, Licette Cécile Yang
Measuring Contractility, Calcium Transients, and Sarcomere Shortening in Adult Canine Cardiomyocytes Treated with Omecamtiv Mecarbil
Hypertrophic Cardiomyopathy Β-Cardiac Myosin Mutation (P710R) Leads to Hypercontractility by Disrupting Super Relaxed State
Treatments Targeting Inotropy
Treatments Targeting Inotropy
Effects of the Cardiac Myosin Activator Omecamtiv-Mecarbil on Severe
Small Molecules Acting on Myofilaments As Treatments
Current and Future Drug and Device Therapies for Pediatric Heart Failure Patients: Potential Lessons from Adult Trials
Influence of Atrial Fibrillation on Efficacy and Safety of Omecamtiv Mecarbil in Heart Failure: the GALACTIC-HF Trial
Top View
Omecamtiv Mecarbil Enhances the Duty Ratio of Humanβ-Cardiac
FDA Grants Fast Track Designation for Omecamtiv Mecarbil in Heart Failure
Multiparametric Mechanistic Profiling of Inotropic Drugs in Adult Human
Omecamtiv Mecarbil a Cardiac Myosin Activator
Highly Selective Inhibition of Myosin Motors Provides the Basis of Potential Therapeutic Application
Omecamtiv Mecarbil for Systolic Heart Failure Manuru Mukhyaprana Prabhu1, Subish Palaian2, Padma Kumar3
New Therapies for the Treatment of Heart Failure: a Summary of Recent Accomplishments
Omecamtiv Mecarbil in Chronic Heart€Failure with Reduced Ejection Fraction
Positive Cardiac Inotrope, Omecamtiv Mecarbil, Activates Muscle Despite Suppressing the Myosin Working Stroke
Discovery & Development of the Cardiac Myosin Activator
Omecamtiv Mecarbil: a Novel Mechanistic and Therapeutic Approach to Chronic Heart Failure Management
Heart Failure Drug Changes the Mechanoenzymology of the Cardiac